Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Rating of “Hold” from Analysts

Ardent Health, Inc. (NYSE:ARDT) has earned a consensus rating of “Hold” from the twelve brokerages that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating on the company. The average 1-year target price among analysts that have covered the stock in the last year is $14.5833.

Several research analysts have recently weighed in on ARDT shares. Weiss Ratings restated a “sell (d)” rating on shares of Ardent Health in a research note on Monday, December 29th. Morgan Stanley reiterated an “equal weight” rating and issued a $12.00 price objective (down previously from $22.00) on shares of Ardent Health in a report on Friday, November 14th. Stephens decreased their price objective on shares of Ardent Health from $21.00 to $17.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Guggenheim lowered their target price on Ardent Health from $18.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday, November 18th. Finally, JPMorgan Chase & Co. cut their price target on Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 20th.

Ardent Health News Roundup

Here are the key news stories impacting Ardent Health this week:

• Neutral Sentiment: Multiple national plaintiff firms are actively soliciting Ardent investors and reminding holders of the March 9, 2026 lead‑plaintiff deadline — a procedural development that increases class‑action activity but does not itself create new allegations. ROSEN: ARDT Final Deadline
• Negative Sentiment: Allegations of undisclosed collections problems and related securities‑fraud claims have been publicized by several firms; one complaint ties prior company statements to a sharp (~33%) stock decline and seeks lead plaintiffs for a federal action pending in the Middle District of Tennessee — this increases litigation and reputational risk for ARDT. KSF: Securities Fraud Class Action
• Negative Sentiment: Hagens Berman and other firms highlight an alleged “$97M accounting shock” and the company’s prior use of a rigid “180‑day cliff” to reserve uncollectible accounts — if true, this could imply material prior misstatements, greater reserve volatility, or future restatements that would materially affect earnings and leverage. Hagens Berman: $97M Accounting Shock

Ardent Health Stock Up 2.0%

NYSE ARDT opened at $9.80 on Friday. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67. Ardent Health has a fifty-two week low of $8.07 and a fifty-two week high of $15.59. The business has a 50 day moving average price of $8.84 and a two-hundred day moving average price of $11.20. The stock has a market cap of $1.40 billion, a PE ratio of 6.76, a P/E/G ratio of 5.56 and a beta of 0.72.

Institutional Trading of Ardent Health

A number of hedge funds have recently made changes to their positions in ARDT. Caitong International Asset Management Co. Ltd raised its holdings in Ardent Health by 1,177.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after acquiring an additional 2,638 shares in the last quarter. CWM LLC increased its position in shares of Ardent Health by 990.6% in the 2nd quarter. CWM LLC now owns 2,203 shares of the company’s stock worth $30,000 after purchasing an additional 2,001 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of Ardent Health in the 3rd quarter worth about $61,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Ardent Health in the 3rd quarter valued at about $80,000. Finally, New York State Common Retirement Fund raised its stake in shares of Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares in the last quarter.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.